Key result
LAAO plus ablation shows promise as rescue or dose-sparing strategy alongside anticoagulation in AF.
Why the study?
Oral anticoagulation is the standard for stroke prevention in AF, but bleeding, non-persistence, and thromboembolism despite treatment create important unmet needs. Catheter ablation and LAAO address distinct mechanisms and do not reproduce systemic anticoagulation.
Does left atrial appendage occlusion prevent stroke in patients with atrial fibrillation?
Does left atrial appendage occlusion prevent stroke in patients with atrial fibrillation?
This narrative review synthesizes evidence on left atrial appendage occlusion and catheter ablation for stroke prevention in atrial fibrillation, highlighting the need to investigate LAAO as a rescue therapy when oral anticoagulation cannot be sustained or as a dose-sparing complement.
Highlights potential rescue role for LAAO and ablation in OAC-intolerant AF; leaves open confirmation in prospective trials.
Introduction Oral anticoagulation (OAC) remains the standard for stroke prevention in atrial fibrillation (AF), but bleeding, non-persistence and thromboembolism despite treatment create important unmet needs. Catheter ablation and left atrial appendage occlusion (LAAO) address distinct mechanisms and do not reproduce systemic anticoagulation.Areas covered This narrative review covers randomized anticoagulation-withdrawal studies after ablation, trials and pooled evidence on LAAO, patients unable to sustain anticoagulation, procedural imaging and healing, post-implant antithrombotic therapy, and future trial design. Targeted searches of PubMed/MEDLINE and ClinicalTrials.gov were supplemented by citation screening and review of contemporary congress reports, for evidence spanning 2005–10 October 2026.Expert opinion The completed randomized LAAO programme mainly tests substitution where OAC remains feasible. Precision source control should be investigated as rescue when OAC cannot be sustained and as a potential dose-sparing complement in selected patients, while addressing residual ischemic risk and verifying durable closure.
No takes yet. Share an insight, caveat, or question.
Samaras et al. (2026) conducted a review in Atrial fibrillation. Left atrial appendage occlusion (LAAO) and catheter ablation vs. Oral anticoagulation (OAC) was evaluated on Stroke prevention in atrial fibrillation. Left atrial appendage occlusion and catheter ablation should be investigated as rescue when oral anticoagulation cannot be sustained and as a dose-sparing complement in atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: